Table 1.
Baseline characteristics
| Characteristic | ILD (N = 4) |
Non-ILD (N = 53) |
Total (N = 57) |
|---|---|---|---|
| Age—years | |||
| Median | 67 | 65 | 66 |
| Range | 64–76 | 25–80 | 25–80 |
| Age group—no. (%) | |||
| <60 years | 0 (0) | 9 (17) | 9 (16) |
| ≥60 years | 4 (100) | 44 (83) | 48 (84) |
| Sex—no. (%) | |||
| Female | 2 (50) | 26 (49) | 28 (49) |
| Male | 2 (50) | 27 (51) | 29 (51) |
| ECOG PS—no. (%) | |||
| 0 | 2 (50) | 8 (15) | 10 (18) |
| 1 | 2 (50) | 45 (85) | 47 (82) |
| Smoking history—no. (%) | |||
| Never smoker | 2 (50) | 25 (47) | 27 (47) |
| Ex-smoker | 2 (50) | 24 (45) | 26 (46) |
| Current smoker | 0 (0) | 4 (8) | 4 (7) |
| Extent of disease—no. (%) | |||
| Metastatic | 3 (75) | 32 (60) | 35 (61) |
| Locally advanced | 1 (25) | 21 (40) | 22 (39) |
| Site of metastatic disease—no. (%) | |||
| Lung | 1 (25) | 8 (15) | 9 (16) |
| Liver | 3 (75) | 21 (40) | 23 (40) |
| Peritoneum | 0 (0) | 14 (26) | 14 (25) |
| Other | 0 (0) | 1 (2) | 1 (2) |
| Number of metastatic site—no. (%) | |||
| <3 | 4 (100) | 51 (96) | 55 (96) |
| ≥3 | 0 (0) | 2 (4) | 2 (4) |
ILD interstitial lung disease, ECOG PS Eastern Cooperative Oncology Group performance status